0.8764
3.35%
0.0284
시간 외 거래:
.88
0.0036
+0.41%
Revelation Biosciences Inc (REVB) 재무 분석
손익 계산서
분기별
*모든 숫자는 백만 단위입니다.
기간 종료일 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 | 2023-03-31 |
기간 | 3개월 | 3개월 | 3개월 | 3개월 | 3개월 |
Revenues |
-
|
- | - | - | - |
Operating Expenses
|
18.22%
1.9021
|
2.3259 | 2.7779 | 1.933 | 1.6198 |
Operating Income/Loss |
18.22%
-1.9021
|
-2.3259 | -2.7779 | -1.933 | -1.6198 |
Nonoperating Income/Loss |
733.64%
-0.7793
|
0.123 | 0.1495 | 0.4849 | 7.779 |
Income/Loss From Continuing Operations Before Tax |
21.72%
-2.6814
|
-2.2029 | -2.6284 | -1.4482 | 6.1592 |
Income Tax Expense/Benefit |
-
|
- | - | - | - |
Income/Loss From Continuing Operations After Tax |
21.72%
-2.6814
|
-2.2029 | -2.6284 | -1.4482 | 6.1592 |
Net Income/Loss
|
21.72%
-2.6814
|
-2.2029 | -2.6284 | -1.4482 | 6.1592 |
Preferred Stock Dividends And Other Adjustments |
-
|
- | - | - | - |
Attributable To Noncontrolling Interest |
-
|
- | - | - | - |
Basic Average Shares |
123.54%
1.0898
|
-4.629 | 6.2973 | 5.8123 | 2.2107 |
Diluted Average Shares |
122.73%
1.0898
|
-4.7955 | 6.2973 | 5.8123 | 3.1359 |
Basic Earnings Per Share |
156.25%
-2.46
|
-0.96 | -0.42 | -0.25 | 2.79 |
Diluted Earnings Per Share |
161.70%
-2.46
|
-0.94 | -0.42 | -0.25 | 1.96 |
Participating Securities, Distributed And Undistributed Earnings/Loss, Basic |
-
|
- | - | - | - |
자본화:
|
볼륨(24시간):